成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>196612-93-8

196612-93-8

中文名稱 FALNIDAMOL
英文名稱 BIBX 1382 DIHYDROCHLORIDE
CAS 196612-93-8
分子式 C18H19ClFN7
分子量 387.84
MOL 文件 196612-93-8.mol
更新日期 2024/06/17 17:25:41
196612-93-8 結(jié)構(gòu)式 196612-93-8 結(jié)構(gòu)式

基本信息

中文別名
N8-(3-氯-4-氟苯基)-N2-(1-甲基-4-哌啶基)嘧啶并[5,4-D]嘧啶-2,8-二胺
英文別名
Falnid
CS-928
Falnidamol
Unii-0mu316797d
Falnidamol [inn]
BIBX 1382 DIHYDROCHLORIDE
FALNIDAMOL
BIBX-1382
BIBX 1382
8-(3-Chloro-4-fluoroanilino)-2-((1-methyl-4-piperidyl)amino)pyrimido(5,4-D)pyrimidine
N4-(3-chloro-4-fluoro-phenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine
N8-(3-Chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-2,8-diamine

物理化學(xué)性質(zhì)

熔點(diǎn)>217°C (dec.)
沸點(diǎn)552.0±60.0 °C(Predicted)
密度1.427
儲(chǔ)存條件Keep in dark place,Inert atmosphere,2-8°C
溶解度可溶于DMSO(少許)、甲醇(少許)
酸度系數(shù)(pKa)8?+-.0.10(Predicted)
形態(tài)固體
顏色淡黃色至黃色

安全數(shù)據(jù)

危險(xiǎn)性符號(hào)(GHS)GHS hazard pictograms
GHS07
警示詞警告
危險(xiǎn)性描述H302-H315-H319-H335
防范說(shuō)明P261-P305+P351+P338

常見(jiàn)問(wèn)題列表

生物活性
Falnidamol (BIBX 1382) 是一種具有口服活性的,選擇性的 EGFR 酪氨酸激酶抑制劑,IC50 為3 nM。Falnidamol 對(duì) ErbB2 (IC50=3.4 μM) 和其他一系列相關(guān)酪氨酸激酶 (IC50>10 μM) 的選擇性 >1000倍。Falnidamol 是嘧啶-嘧啶化合物,具有抗癌活性。
靶點(diǎn)

EGFR

3 nM (IC 50 )

ErbB2

3.4 μM (IC 50 )

體外研究

Falnidamol (BIBX 1382) demonstrates antiproliferative activity in mitogenic assays performed with KB cells.

體內(nèi)研究

Falnidamol (BIBX 1382; p.o.; 10 mg/kg/day; 16 days) completely suppressed tumor growth of human A431 xenografts with respective a T/C value of 15% after 2 weeks of treatment.
Falnidamol (50 mg/kg/day for 2 weeks) results in dephosphorylation of the EGF receptor in A431 xenograft-bearing mice.
With Falnidamol (p.o.; 10 mg/kg/day; 16 days), the C 4h is 2222 nM and the C 24h is 244 nM.

Animal Model: Five- to six-week-old athymic NMRI-nu/nu female mice (21-31 g) with A431, FaDu, or HN5 cells
Dosage: 10 mg/kg
Administration: p.o.; daily; 16 days
Result: Completely suppressed tumor growth of human A431 xenografts with respective T/C values of 15 and 6% after 2 weeks of treatment.
Animal Model: Five- to six-week-old athymic NMRI-nu/nu female mice (21–31 g) with A431 cells
Dosage: 10 mg/kg (Pharmacokinetic Analysis)
Administration: p.o.; daily; 16 days
Result: The C 4h is 2222 nM and the C 24h is 244 nM.
"196612-93-8" 相關(guān)產(chǎn)品信息